Our calendar informs on industry events, upcoming compliance deadlines, as well as new Obelis webinars.
Canada - Fragrance Allergen Disclosure Deadline ✅12 April 2026: New and existing cosmetics have to disclose the 24 fragrance allergens listed below within the list of ingredients, when present at concentration greater than 0.01% in rinse-off products and 0.001% in leave-on products. To ensure compliance with the above regulatory changes, we recommend reviewing and, where…
European Union - Omnibus Act VIII amends the Cosmetic Regulations ✅1 May 2026: Products containing 3-(4′-methylbenzylidene)-camphor (CAS No 36861-47-9/38102-62-4) can no longer be made available on the market. ✅1 May 2026: With no distinction between placing products on the market and making them available, Omnibus Act VIII will apply. This means that, from the application date, non-compliant cosmetics can…
As the transition to the In Vitro Diagnostic Regulation (IVDR) continues, we would like to remind you of the critical 2026 deadlines for legacy IVDs that are classified to Class C under IVDR. For these devices, the following milestones apply: ✅A written agreement between the manufacturer and the Notified Body must be signed by 26 September 2026. ✅The manufacturer or their Authorised…
Regulatory Alert | EUDAMED becomes mandatory Commission Decision (EU) 2025/2371 confirms the full functionality of the first four EUDAMED modules. As a result, economic operators must comply with mandatory registration requirements. Mandatory modules from 28 May 2026: ✅Market Surveillance ✅Actors: registration of manufacturers, authorised representatives, importers ✅UDI / Devices: device registration (excluding custom-made devices) ✅Notified Bodies &…
Join us for an expert-led session on navigating cosmetic safety in a complex global regulatory landscape. As cosmetic products cross borders, ensuring compliance is no longer a one-time task, it requires a strategic, science-driven approach that integrates multiterritory safety assessment, robust laboratory testing, and continuously updated documentation. In this webinar, we will explore how laboratory…
From 1 July 2026, manufacturers placing medical devices and IVDs on the Swiss market must ensure their devices are registered in swissdamed, Switzerland’s national medical device database managed by Swissmedic. The deadline introduces new registration and compliance responsibilities for both manufacturers and their Swiss Authorised Representatives, making swissdamed registration an essential part of maintaining access…
Starting on 31 July 2026, cosmetic products placed on the EU market must comply with the updated labelling requirements, including the disclosure of 56 additional fragrance allergens where applicable. From this date onwards: ✅ Products that do not meet the updated labelling requirements may be held at customs, refused entry, or removed from the market…
Commission Decision (EU) 2025/2371 triggered the transition period leading to the 27 November 2026 deadline for the registration of legacy devices in EUDAMED. With the deadline approaching, manufacturers should ensure that the required device information is complete, accurate, and ready for registration. This involves more than entering data into EUDAMED: product and UDI information must…